The US FTC announces launch of inquiry into the prescription drug middleman industry

FTC Launches Inquiry Into Prescription Drug Middlemen Industry* Agency to Scrutinize the Impact of Vertically Integrated Pharmacy Benefit Managers on the Access and Affordability of Medicine The Federal Trade Commission announced today that it will launch an inquiry into the prescription drug middleman industry, requiring the six largest pharmacy benefit managers to provide information and records regarding their business practices. The agency’s inquiry will scrutinize the impact of vertically integrated pharmacy benefit managers on the access and affordability of

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

US Federal Trade Commission, The US FTC announces launch of inquiry into the prescription drug middleman industry, 7 June 2022, e-Competitions June 2022 - II, Art. N° 107006

Visites 254

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues